A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

NCT06161441 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

195

Enrollment

INDUSTRY

Sponsor class

Conditions

Resectable Non-small Cell Lung Cancer

Interventions

DRUG: Fianlimab
DRUG: Cemiplimab
DRUG: Pemetrexed
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals